{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:55:42Z","timestamp":1794264942435,"version":"4.9.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7232016"],"award-info":[{"award-number":["7232016"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["Z200015"],"award-info":[{"award-number":["Z200015"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7222021"],"award-info":[{"award-number":["7222021"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91959205"],"award-info":[{"award-number":["91959205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203881"],"award-info":[{"award-number":["82203881"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006739","name":"Capital Foundation of Medical Development","doi-asserted-by":"publisher","award":["2020-1-1022"],"award-info":[{"award-number":["2020-1-1022"]}],"id":[{"id":"10.13039\/501100006739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2021-02-15"],"award-info":[{"award-number":["320.6750.2021-02-15"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gastric cancer with peritoneal metastasis (PM-GC), recognized as one of the deadliest cancers. However, whether and how the tumor cell-extrinsic tumor microenvironment (TME) is involved in the therapeutic failure remains unknown. Thus, this study systematically assessed the immunosuppressive tumor microenvironment in ascites from patients with PM-GC, and its contribution to dissemination and immune evasion of ascites-disseminated tumor cells (aDTCs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Sixty-three ascites and 43 peripheral blood (PB) samples from 51 patients with PM-GC were included in this study. aDTCs in ascites and circulating tumor cells (CTCs) in paired PB were immunophenotypically profiled. Using single-cell RNA transcriptional sequencing (scRNA-seq), crosstalk between aDTCs and the TME features of ascites was inspected. Further studies on the mechanism underlying aDTCs-immune cells crosstalk were performed on in vitro cultured aDTCs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Immune cells in ascites interact with aDTCs, prompting their immune evasion. Specifically, we found that the tumor-associated macrophages (TAMs) in ascites underwent a continuum lineage transition from cathepsin<jats:sup><jats:italic>high<\/jats:italic><\/jats:sup> (CTS<jats:sup><jats:italic>high<\/jats:italic><\/jats:sup>) to complement 1q<jats:sup><jats:italic>high<\/jats:italic><\/jats:sup> (C1Q<jats:sup><jats:italic>high<\/jats:italic><\/jats:sup>) TAM. CTS<jats:sup><jats:italic>high<\/jats:italic><\/jats:sup> TAM initially attracted the metastatic tumor cells to ascites, thereafter, transitioning terminally to C1Q<jats:sup><jats:italic>high<\/jats:italic><\/jats:sup> TAM to trigger overproliferation and immune escape of aDTCs. Mechanistically, we demonstrated that C1Q<jats:sup><jats:italic>high<\/jats:italic><\/jats:sup> TAMs significantly enhanced the expression of PD-L1 and NECTIN2 on aDTCs, which was driven by the activation of the C1q-mediated complement pathway.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>For the first time, we identified an immunosuppressive macrophage transition from CTS<jats:sup><jats:italic>high<\/jats:italic><\/jats:sup> to C1Q<jats:sup><jats:italic>high<\/jats:italic><\/jats:sup> TAM in ascites from patients with PM-GC. This may contribute to developing potential TAM-targeted immunotherapies for PM-GC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                <jats:p><jats:bold>Schematic of the immune TME of ascites and the crosstalk with aDTCs in patients with PM-GC<\/jats:bold>. In ascites with TAM-dominant TME, the ascitic TAMs undergo CTS-to-C1Q transition to support multiple phases of aDTC dissemination, including aDTC homing, proliferation, immune escape, and therapeutic resistance. While in ascites with T-cell-dominant TME, enriched T cells do not imply \u201cimmune-hot\u201d TME. Infiltrated CD8<jats:sup>+<\/jats:sup> T cells are GZMK<jats:sup>+<\/jats:sup> precursor-exhausted cells that have lost their capacity to kill tumor cells. (Abbreviations: <jats:italic>aDTC<\/jats:italic> ascites-disseminated tumor cells, <jats:italic>CTS<\/jats:italic> cathepsin, <jats:italic>TAM<\/jats:italic> Tumor-associated macrophages, <jats:italic>TME<\/jats:italic> tumor microenvironment)<\/jats:p>\n                \n              <\/jats:sec>","DOI":"10.1007\/s10120-024-01486-6","type":"journal-article","created":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T12:01:47Z","timestamp":1709985707000},"page":"519-538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Specific lineage transition of tumor-associated macrophages elicits immune evasion of ascitic tumor cells in gastric cancer with peritoneal metastasis"],"prefix":"10.1007","volume":"27","author":[{"given":"Yilin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengde","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujiao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1134-2922","authenticated-orcid":false,"given":"Lin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,9]]},"reference":[{"issue":"1","key":"1486_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41572-021-00326-6","volume":"7","author":"D Cort\u00e9s-Guiral","year":"2021","unstructured":"Cort\u00e9s-Guiral D, H\u00fcbner M, Alyami M, et al. Primary and metastatic peritoneal surface malignancies. Nat Rev Dis Primers. 2021;7(1):91.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"1486_CR2","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s10120-021-01160-1","volume":"24","author":"WJ Koemans","year":"2021","unstructured":"Koemans WJ, Lurvink RJ, Grootscholten C, et al. Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort. Gastric Cancer. 2021;24(4):800\u20139.","journal-title":"Gastric Cancer"},{"issue":"10251","key":"1486_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020;396(10251):635\u201348.","journal-title":"Lancet"},{"issue":"5","key":"1486_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100244","volume":"6","author":"EB Ulas","year":"2021","unstructured":"Ulas EB, Dickhoff C, Schneiders FL, et al. Neoadjuvant immune checkpoint inhibitors in resectable non-small-cell lung cancer: a systematic review. ESMO Open. 2021;6(5): 100244.","journal-title":"ESMO Open"},{"issue":"10","key":"1486_CR5","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1001\/jamaoncol.2019.2187","volume":"5","author":"SL Topalian","year":"2019","unstructured":"Topalian SL, Hodi FS, Brahmer JR, et al. Five-Year survival and correlates among patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with Nivolumab. JAMA Oncol. 2019;5(10):1411\u201320.","journal-title":"JAMA Oncol"},{"key":"1486_CR6","doi-asserted-by":"crossref","unstructured":"Diaz LA, Le DT, Yoshino T, et al. KEYNOTE-177: Phase 3, open-label, randomized study of first-line pembrolizumab (Pembro) versus investigator-choice chemotherapy for mismatch repair-deficient (dMMR) or microsatellite instability-high (MSI-H) metastatic colorectal carcinoma (mCRC). J Clin Oncol. 2018;36(4_suppl):S877.","DOI":"10.1200\/JCO.2018.36.4_suppl.TPS877"},{"issue":"2","key":"1486_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004001","volume":"10","author":"G Fuc\u00e0","year":"2022","unstructured":"Fuc\u00e0 G, Cohen R, Lonardi S, et al. Ascites and resistance to immune checkpoint inhibition in dMMR\/MSI-H metastatic colorectal and gastric cancers. J Immunother Cancer. 2022;10(2): e004001.","journal-title":"J Immunother Cancer"},{"issue":"9","key":"1486_CR8","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s43018-021-00240-6","volume":"2","author":"Y Tanaka","year":"2021","unstructured":"Tanaka Y, Chiwaki F, Kojima S, et al. Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities. Nat Cancer. 2021;2(9):962\u201377.","journal-title":"Nat Cancer"},{"issue":"1","key":"1486_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/gutjnl-2018-318070","volume":"69","author":"R Wang","year":"2020","unstructured":"Wang R, Song S, Harada K, et al. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut. 2020;69(1):18\u201331.","journal-title":"Gut"},{"issue":"1","key":"1486_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41591-020-1125-8","volume":"27","author":"R Wang","year":"2021","unstructured":"Wang R, Dang M, Harada K, et al. Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma. Nat Med. 2021;27(1):141\u201351.","journal-title":"Nat Med"},{"issue":"11","key":"1486_CR11","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1158\/1078-0432.CCR-19-3231","volume":"26","author":"A Sathe","year":"2020","unstructured":"Sathe A, Grimes SM, Lau BT, et al. Single-cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment. Clin Cancer Res. 2020;26(11):2640\u201353.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1486_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41568-021-00366-w","volume":"21","author":"D Bayik","year":"2021","unstructured":"Bayik D, Lathia JD. Cancer stem cell-immune cell crosstalk in tumour progression. Nat Rev Cancer. 2021;21(8):526\u201336.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"1486_CR13","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/obr.12450","volume":"17","author":"GH Chkourko","year":"2016","unstructured":"Chkourko GH, Diedrich J, MacDougald OA, et al. Omentum and bone marrow: how adipocyte-rich organs create tumour microenvironments conducive for metastatic progression. Obes Rev. 2016;17(11):1015\u201329.","journal-title":"Obes Rev"},{"issue":"2","key":"1486_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.canlet.2014.05.008","volume":"352","author":"QM Fan","year":"2014","unstructured":"Fan QM, Jing YY, Yu GF, et al. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett. 2014;352(2):160\u20138.","journal-title":"Cancer Lett"},{"key":"1486_CR15","doi-asserted-by":"publisher","first-page":"15080","DOI":"10.1038\/ncomms15080","volume":"8","author":"Y Shi","year":"2017","unstructured":"Shi Y, Ping YF, Zhou W, et al. Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth. Nat Commun. 2017;8:15080.","journal-title":"Nat Commun"},{"issue":"12","key":"1486_CR16","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1038\/s12276-020-00538-y","volume":"52","author":"HH Eum","year":"2020","unstructured":"Eum HH, Kwon M, Ryu D, et al. Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer. Exp Mol Med. 2020;52(12):1976\u201388.","journal-title":"Exp Mol Med"},{"key":"1486_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ebiom.2018.08.005","volume":"35","author":"X Liu","year":"2018","unstructured":"Liu X, Zhang Z, Zhang B, et al. Circulating tumor cells detection in neuroblastoma patients by EpCAM-independent enrichment and immunostaining-fluorescence in situ hybridization. EBioMedicine. 2018;35:244\u201350.","journal-title":"EBioMedicine"},{"issue":"21","key":"1486_CR18","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.1158\/1078-0432.CCR-18-1205","volume":"24","author":"Y Li","year":"2018","unstructured":"Li Y, Zhang X, Liu D, et al. Evolutionary expression of HER2 conferred by chromosome aneuploidy on circulating gastric cancer cells contributes to developing targeted and chemotherapeutic resistance. Clin Cancer Res. 2018;24(21):5261\u201371.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"1486_CR19","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411\u201320.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"1486_CR20","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nbt.4201","volume":"36","author":"TC Branon","year":"2018","unstructured":"Branon TC, Bosch JA, Sanchez AD, et al. Efficient proximity labeling in living cells and organisms with TurboID. Nat Biotechnol. 2018;36(9):880\u20137.","journal-title":"Nat Biotechnol"},{"issue":"11","key":"1486_CR21","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1080\/15476286.2021.1873620","volume":"18","author":"Y Li","year":"2021","unstructured":"Li Y, Liu S, Cao L, et al. CBRPP: a new RNA-centric method to study RNA-protein interactions. RNA Biol. 2021;18(11):1608\u201321.","journal-title":"RNA Biol"},{"issue":"1","key":"1486_CR22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s40425-019-0708-8","volume":"7","author":"HS Park","year":"2019","unstructured":"Park HS, Kwon WS, Park S, et al. Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer. J Immunother Cancer. 2019;7(1):268.","journal-title":"J Immunother Cancer"},{"issue":"11","key":"1486_CR23","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/iub.2558","volume":"73","author":"R Hosseinzadeh","year":"2021","unstructured":"Hosseinzadeh R, Feizisani F, Shomali N, et al. PD-1\/PD-L1 blockade: prospectives for immunotherapy in cancer and autoimmunity. IUBMB Life. 2021;73(11):1293\u2013306.","journal-title":"IUBMB Life"},{"issue":"4","key":"1486_CR24","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.biotechadv.2018.05.002","volume":"36","author":"M Umer","year":"2018","unstructured":"Umer M, Vaidyanathan R, Nguyen NT, et al. Circulating tumor microemboli: progress in molecular understanding and enrichment technologies. Biotechnol Adv. 2018;36(4):1367\u201389.","journal-title":"Biotechnol Adv"},{"key":"1486_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.canlet.2021.06.002","volume":"517","author":"Y Chen","year":"2021","unstructured":"Chen Y, Li Y, Qi C, et al. Dysregulated KRAS gene-signaling axis and abnormal chromatin remodeling drive therapeutic resistance in heterogeneous-sized circulating tumor cells in gastric cancer patients. Cancer Lett. 2021;517:78\u201387.","journal-title":"Cancer Lett"},{"issue":"9","key":"1486_CR26","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim ST, Cristescu R, Bass AJ, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24(9):1449\u201358.","journal-title":"Nat Med"},{"issue":"1","key":"1486_CR27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s40425-019-0768-9","volume":"7","author":"AA Davis","year":"2019","unstructured":"Davis AA, Patel VG. The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors. J Immunother Cancer. 2019;7(1):278.","journal-title":"J Immunother Cancer"},{"issue":"7848","key":"1486_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41586-021-03234-7","volume":"591","author":"AJ Combes","year":"2021","unstructured":"Combes AJ, Courau T, Kuhn NF, et al. Global absence and targeting of protective immune states in severe COVID-19. Nature. 2021;591(7848):124\u201330.","journal-title":"Nature"},{"issue":"3","key":"1486_CR29","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","volume":"178","author":"CS Smillie","year":"2019","unstructured":"Smillie CS, Biton M, Ordovas-Montanes J, et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell. 2019;178(3):714\u201330.","journal-title":"Cell"},{"issue":"5","key":"1486_CR30","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.immuni.2019.09.008","volume":"51","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, Liu C, Gong Y, et al. Single-cell RNA sequencing resolves spatiotemporal development of pre-thymic lymphoid progenitors and thymus organogenesis in human embryos. Immunity. 2019;51(5):930\u201348.","journal-title":"Immunity"},{"issue":"1","key":"1486_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41467-019-14118-w","volume":"11","author":"D Schafflick","year":"2020","unstructured":"Schafflick D, Xu CA, Hartlehnert M, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11(1):247.","journal-title":"Nat Commun"},{"issue":"6","key":"1486_CR32","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","volume":"182","author":"A Silvin","year":"2020","unstructured":"Silvin A, Chapuis N, Dunsmore G, et al. Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell. 2020;182(6):1401\u201318.","journal-title":"Cell"},{"issue":"5","key":"1486_CR33","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.ccell.2020.08.014","volume":"38","author":"R Dong","year":"2020","unstructured":"Dong R, Yang R, Zhan Y, et al. Single-cell characterization of malignant phenotypes and developmental trajectories of adrenal neuroblastoma. Cancer Cell. 2020;38(5):716\u201333.","journal-title":"Cancer Cell"},{"issue":"7","key":"1486_CR34","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41591-020-0944-y","volume":"26","author":"AJ Wilk","year":"2020","unstructured":"Wilk AJ, Rustagi A, Zhao NQ, et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat Med. 2020;26(7):1070\u20136.","journal-title":"Nat Med"},{"issue":"1","key":"1486_CR35","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J, Sun H, Zhang Y, et al. Single-cell and spatial analysis reveal interaction of FAP (+) fibroblasts and SPP1 (+) macrophages in colorectal cancer. Nat Commun. 2022;13(1):1742.","journal-title":"Nat Commun"},{"key":"1486_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2019.105572","volume":"114","author":"Y Xie","year":"2019","unstructured":"Xie Y, Liu C, Qin Y, et al. Knockdown of IRE1\u0251 suppresses metastatic potential of colon cancer cells through inhibiting FN1-Src\/FAK-GTPases signaling. Int J Biochem Cell Biol. 2019;114: 105572.","journal-title":"Int J Biochem Cell Biol"},{"key":"1486_CR37","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1111\/cas.15567","volume":"113","author":"B Ma","year":"2022","unstructured":"Ma B, Ueda H, Okamoto K, et al. TIMP1 promotes cell proliferation and invasion capability of right-sided colon cancers via the FAK\/Akt signaling pathway. Cancer Sci. 2022;113:4244\u201357.","journal-title":"Cancer Sci"},{"issue":"1","key":"1486_CR38","doi-asserted-by":"publisher","first-page":"1846915","DOI":"10.1080\/2162402X.2020.1846915","volume":"9","author":"RA de Azevedo","year":"2020","unstructured":"de Azevedo RA, Shoshan E, Whang S, et al. MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma. Oncoimmunology. 2020;9(1):1846915.","journal-title":"Oncoimmunology"},{"issue":"8","key":"1486_CR39","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/j.celrep.2019.07.068","volume":"28","author":"D Di Mitri","year":"2019","unstructured":"Di Mitri D, Mirenda M, Vasilevska J, et al. Re-education of tumor-associated macrophages by CXCR2 blockade drives senescence and tumor inhibition in advanced prostate cancer. Cell Rep. 2019;28(8):2156\u201368.","journal-title":"Cell Rep"},{"issue":"7","key":"1486_CR40","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.7150\/ijbs.70524","volume":"18","author":"Y Fang","year":"2022","unstructured":"Fang Y, Dou R, Huang S, et al. LAMC1-mediated preadipocytes differentiation promoted peritoneum pre-metastatic niche formation and gastric cancer metastasis. Int J Biol Sci. 2022;18(7):3082\u2013101.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"1486_CR41","doi-asserted-by":"publisher","first-page":"3648","DOI":"10.7150\/jca.52851","volume":"12","author":"Q Jin","year":"2021","unstructured":"Jin Q, Ren Q, Chang X, et al. Neuropilin-1 predicts poor prognosis and promotes tumor metastasis through epithelial-mesenchymal transition in gastric cancer. J Cancer. 2021;12(12):3648\u201359.","journal-title":"J Cancer"},{"issue":"2","key":"1486_CR42","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1365-2613.2012.00810.x","volume":"93","author":"JR Wild","year":"2012","unstructured":"Wild JR, Staton CA, Chapple K, et al. Neuropilins: expression and roles in the epithelium. Int J Exp Pathol. 2012;93(2):81\u2013103.","journal-title":"Int J Exp Pathol"},{"issue":"5","key":"1486_CR43","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.3390\/ijms22052634","volume":"22","author":"RM Urbantat","year":"2021","unstructured":"Urbantat RM, Blank A, Kremenetskaia I, et al. The CXCL2\/IL8\/CXCR2 pathway is relevant for brain tumor malignancy and endothelial cell function. Int J Mol Sci. 2021;22(5):2634.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1486_CR44","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1158\/0008-5472.CAN-21-0184","volume":"81","author":"HW Leung","year":"2021","unstructured":"Leung HW, Leung C, Lau EY, et al. EPHB2 activates \u03b2-catenin to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma. Cancer Res. 2021;81(12):3229\u201340.","journal-title":"Cancer Res"},{"issue":"1","key":"1486_CR45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12943-019-1073-4","volume":"18","author":"S Peng","year":"2019","unstructured":"Peng S, Wang R, Zhang X, et al. EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression. Mol Cancer. 2019;18(1):165.","journal-title":"Mol Cancer"},{"issue":"1","key":"1486_CR46","doi-asserted-by":"publisher","first-page":"6352","DOI":"10.1038\/s41467-020-20260-7","volume":"11","author":"JB Wang","year":"2020","unstructured":"Wang JB, Li P, Liu XL, et al. An immune checkpoint score system for prognostic evaluation and adjuvant chemotherapy selection in gastric cancer. Nat Commun. 2020;11(1):6352.","journal-title":"Nat Commun"},{"issue":"10","key":"1486_CR47","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41389-021-00355-6","volume":"10","author":"K Xu","year":"2021","unstructured":"Xu K, Wang R, Xie H, et al. Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis. Oncogenesis. 2021;10(10):66.","journal-title":"Oncogenesis"},{"issue":"1","key":"1486_CR48","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s43018-021-00292-8","volume":"3","author":"B Liu","year":"2022","unstructured":"Liu B, Hu X, Feng K, et al. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat Cancer. 2022;3(1):108\u201321.","journal-title":"Nat Cancer"},{"issue":"2","key":"1486_CR49","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","volume":"184","author":"Y Sun","year":"2021","unstructured":"Sun Y, Wu L, Zhong Y, et al. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell. 2021;184(2):404\u201321.","journal-title":"Cell"},{"issue":"8","key":"1486_CR50","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41590-021-00967-5","volume":"22","author":"S Hangai","year":"2021","unstructured":"Hangai S, Kawamura T, Kimura Y, et al. Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells. Nat Immunol. 2021;22(8):947\u201357.","journal-title":"Nat Immunol"},{"issue":"7","key":"1486_CR51","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.trecan.2022.02.006","volume":"8","author":"M Revel","year":"2022","unstructured":"Revel M, Saut\u00e8s-Fridman C, Fridman WH, et al. C1q+ macrophages: passengers or drivers of cancer progression. Trends Cancer. 2022;8(7):517\u201326.","journal-title":"Trends Cancer"},{"issue":"1","key":"1486_CR52","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13059-020-02222-w","volume":"22","author":"J Yang","year":"2021","unstructured":"Yang J, Lin P, Yang M, et al. Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma. Genome Biol. 2021;22(1):4.","journal-title":"Genome Biol"},{"issue":"11","key":"1486_CR53","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1016\/j.cell.2021.04.038","volume":"184","author":"A Obradovic","year":"2021","unstructured":"Obradovic A, Chowdhury N, Haake SM, et al. Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages. Cell. 2021;184(11):2988\u20133005.","journal-title":"Cell"},{"issue":"7","key":"1486_CR54","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1158\/2326-6066.CIR-18-0891","volume":"7","author":"LT Roumenina","year":"2019","unstructured":"Roumenina LT, Daugan MV, No\u00e9 R, et al. Tumor cells Hijack macrophage-produced complement C1q to promote tumor growth. Cancer Immunol Res. 2019;7(7):1091\u2013105.","journal-title":"Cancer Immunol Res"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-024-01486-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-024-01486-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-024-01486-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T13:02:36Z","timestamp":1713099756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-024-01486-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,9]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1486"],"URL":"https:\/\/doi.org\/10.1007\/s10120-024-01486-6","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,9]]},"assertion":[{"value":"30 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethics Committee of our hospital. Written consent forms were received from each patient before specimen collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"J.X. and Y.J. are employees of Singleron Biotechnologies. Other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Yes.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}